Eupraxia Pharmaceuticals Equity Warrants Exp 10th March 2026 EPRX"-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 05/12/22 EDT
0.03UNCH (UNCH)
52 week range
0.03 - 0.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.03
  • 52 Week High0.75
  • 52 Week High Date06/22/21
  • 52 Week Low0.03
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.03
  • 52 Week High0.75
  • 52 Week High Date06/22/21
  • 52 Week Low0.03
  • 52 Week Low Date05/12/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Eupraxia Pharmaceuticals Equity Warrants Exp 10th March 2026

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its lead product candidate, EP-104IAR, is designed to meet the unmet medical need and market demand for long-lasting pain relief for knee osteoarthritis (OA). EP-104IAR contains a solid core of the active ingredient Fluticasone Propionate (FP) with an outer layer of the...
Address
2067 Cadboro Bay Road, #201
Victoria, BC
V8R 5G4
Canada